Chemical activators of SVOP can engage in a variety of molecular interactions to initiate the activation process of this protein. Forskolin directly interacts with adenylate cyclase to boost intracellular cAMP levels, which in turn activates protein kinase A (PKA). The activated PKA can then phosphorylate proteins that are involved in the functional regulation of SVOP, thereby promoting its activation. Similarly, Isoproterenol, by binding to beta-adrenergic receptors, triggers a signaling cascade that also results in elevated cAMP and subsequent PKA-mediated activation of SVOP. The phosphodiesterase inhibitor IBMX contributes to this process by preventing cAMP degradation, sustaining an environment conducive to the phosphorylation and consequent activation of SVOP. In addition, PIP2, a membrane lipid, can influence the membrane dynamics around SVOP, potentially facilitating its activation through changes in localization or interaction with other membrane components.
Calcium ions, introduced into the cell by compounds such as Calcium chloride, can activate calcium-dependent protein kinases, which are capable of phosphorylating and activating SVOP. Calmodulin, which binds calcium ions, can similarly activate various kinases and phosphatases that lead to SVOP activation. The phorbol ester PMA exerts its effects by activating protein kinase C (PKC), which may target SVOP for phosphorylation and activation. The presence of Okadaic acid inhibits protein phosphatases, tipping the balance towards a phosphorylated and active state of SVOP. Anandamide activates cannabinoid receptors, which through their G-proteins, can initiate signaling pathways culminating in SVOP activation. The chelator BAPTA-AM fine-tunes calcium signaling, which can lead to the activation of SVOP through calcium-dependent pathways. Dibutyryl-cAMP (db-cAMP) serves as a synthetic analog of cAMP that diffuses into cells and activates PKA, fostering an environment that supports SVOP phosphorylation and activation. Lastly, Ionomycin raises intracellular calcium levels, potentially activating SVOP through calcium-sensitive signaling mechanisms. Each of these chemicals contributes to a multifaceted regulatory network that ensures the proper activation of SVOP within the cellular context.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased levels of cAMP, which can activate SVOP by promoting the phosphorylation of proteins involved in SVOP's functional regulation or localization. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol binds to beta-adrenergic receptors, initiating a signaling cascade that increases intracellular cAMP, which in turn activates protein kinase A (PKA) that could phosphorylate and activate SVOP. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX inhibits phosphodiesterases, preventing the breakdown of cAMP, thus sustaining PKA activity and possibly leading to the activation of SVOP through increased phosphorylation. | ||||||
Calcium chloride anhydrous | 10043-52-4 | sc-207392 sc-207392A | 100 g 500 g | $65.00 $262.00 | 1 | |
Calcium chloride can increase intracellular calcium levels, which may activate calcium-dependent protein kinases that could phosphorylate and activate SVOP. | ||||||
Calmodulin (human), (recombinant) | 73298-54-1 | sc-471287 | 1 mg | $232.00 | ||
Calmodulin binds calcium and activates various protein kinases and phosphatases, which could lead to the phosphorylation and activation of SVOP. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), which could then phosphorylate SVOP, leading to its activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic acid inhibits protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of cellular proteins, potentially including SVOP, resulting in its activation. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
BAPTA-AM is a cell-permeable calcium chelator that can regulate calcium signaling, potentially leading to the activation of calcium-dependent kinases that activate SVOP. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Dibutyryl-cAMP is a membrane-permeable cAMP analog that can activate PKA, potentially leading to the phosphorylation and activation of SVOP. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, which may activate calcium-dependent signaling pathways resulting in the activation of SVOP. | ||||||